Introduction . Despite the progress that has been made in the therapy of atopic dermatitis in recent years, cyclosporin A remains the first-line treatment of severe forms of the disease. Objective. To present a case of effective cyclosporin A therapy of severe atopic dermatitis with features of secondary bacterial infection. Case report . A 22-year-old man was admitted to hospital with extensive erythematous-desquamative skin lesions. The lesions were accompanied by intense itching. Based on the patient’s medical history, physical examination, laboratory test results and histological examination of a skin biopsy, atopic dermatitis with bacterial superinfection was diagnosed. Treatment with cyclosporin A in combination with antibiotic...
A multicentre, randomized, double-blind, controlled crossover clinical trial was conducted on 33 pat...
Cyclosporine (CS) is widely used in patients with refractory atopic dermatitis (AD). During CS treat...
Systemic therapy is required in patients with severe atopic dermatitis (AD) refractory to adequate t...
Treatment of atopic dermatitis is a most challenging problem of dermatology. Essential role is alloc...
Background: Patients with severe atopic dermatitis (AD) can benefit from cyclosporin (CSA) treatment...
Systemic therapy for atopic dermatitis (AD) is indicated in patients with severe disease refractory ...
Background:Severeatopic dermatitis (AD) remains difficult to treat. Cyclosporine is effective in adu...
textabstractThe efficacy of cyclosporin (Sandimmun®) given in a daily dose of 5 mg/kg for 6 weeks in...
A few patients remain severely affected by atopic dermatitis into adult life despite treatment with...
<em>Atopic dermatitis (AtD) is one of the most widespread types of allergic lesions of skin in child...
Cyclosporine A (CsA) is effective in treating moderate-to-severe atopic dermatitis (AD). This system...
In order to evaluate the effect of Cyclosporin-A (CyA) at doses of 5 mg/kg per day in atopic dermati...
Background: Dermographic urticaria (DU) is characterized by strong itch and wheals induced by mechan...
Atopic dermatitis (AD) is the most frequent chronic inflammatory skin disorder in children and is us...
A group of 18 adult patients, with chronic, severe and therapy-resistant atopic dermatitis, were tre...
A multicentre, randomized, double-blind, controlled crossover clinical trial was conducted on 33 pat...
Cyclosporine (CS) is widely used in patients with refractory atopic dermatitis (AD). During CS treat...
Systemic therapy is required in patients with severe atopic dermatitis (AD) refractory to adequate t...
Treatment of atopic dermatitis is a most challenging problem of dermatology. Essential role is alloc...
Background: Patients with severe atopic dermatitis (AD) can benefit from cyclosporin (CSA) treatment...
Systemic therapy for atopic dermatitis (AD) is indicated in patients with severe disease refractory ...
Background:Severeatopic dermatitis (AD) remains difficult to treat. Cyclosporine is effective in adu...
textabstractThe efficacy of cyclosporin (Sandimmun®) given in a daily dose of 5 mg/kg for 6 weeks in...
A few patients remain severely affected by atopic dermatitis into adult life despite treatment with...
<em>Atopic dermatitis (AtD) is one of the most widespread types of allergic lesions of skin in child...
Cyclosporine A (CsA) is effective in treating moderate-to-severe atopic dermatitis (AD). This system...
In order to evaluate the effect of Cyclosporin-A (CyA) at doses of 5 mg/kg per day in atopic dermati...
Background: Dermographic urticaria (DU) is characterized by strong itch and wheals induced by mechan...
Atopic dermatitis (AD) is the most frequent chronic inflammatory skin disorder in children and is us...
A group of 18 adult patients, with chronic, severe and therapy-resistant atopic dermatitis, were tre...
A multicentre, randomized, double-blind, controlled crossover clinical trial was conducted on 33 pat...
Cyclosporine (CS) is widely used in patients with refractory atopic dermatitis (AD). During CS treat...
Systemic therapy is required in patients with severe atopic dermatitis (AD) refractory to adequate t...